Works by Artime, Esther


Results: 27
    1
    2

    Higher Compliance with Treatment Administration Instructions for Injectable Dulaglutide versus Oral Semaglutide Reported by People with Type 2 Diabetes in Clinical Practice Settings in Spain: The TRU-Experience Study.

    Published in:
    Patient Preference & Adherence, 2025, v. 19, p. 1231, doi. 10.2147/PPA.S509483
    By:
    • Díaz-Cerezo, Silvia;
    • Artime, Esther;
    • Redondo-Antón, Jennifer;
    • Duque, Natalia;
    • Spaepen, Erik;
    • Cruz, Miguel Ángel Mangas;
    • Arnas-Leon, Claudia;
    • Olveira, Gabriel;
    • Rodríguez, Irene Rodríguez;
    • Alagarda, María Teresa Julián;
    • Valdés, Nuria;
    • Merchante, Agustín Ángel;
    • Masmiquel, Lluís;
    • Santos, Miriam Rubio-de
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain.

    Published in:
    Advances in Therapy, 2024, v. 41, n. 9, p. 3569, doi. 10.1007/s12325-024-02938-2
    By:
    • Botana López, Manuel;
    • Camafort Babkowski, Miguel;
    • Campuzano Ruiz, Raquel;
    • Cebrián Cuenca, Ana;
    • Gargallo Fernández, Manuel;
    • David de Paz, Héctor;
    • Redondo-Antón, Jennifer;
    • Artime, Esther;
    • Díaz-Cerezo, Silvia;
    • Rubio de Santos, Miriam
    Publication type:
    Article
    25
    26
    27